Donepezil (Demenza (5 mg)) is a cholinesterase inhibitor, prescribed for dementia of Alzheimer's disease. It works by increasing the amount of acetylcholine in the brain, which helps in improving ...
Dementia with Lewy bodies (DLB) is a common neurodegenerative disorder in which patients exhibit symptoms of dementia and parkinsonism along with fluctuations and hallucinations that can be ...
Donepezil increases the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. There is no evidence that donepezil alters the course of the underlying ...
September 6, 2012 — In a lawsuit filed Wednesday, the consumer advocacy group Public Citizen has asked the court to compel the US Food and Drug Administration (FDA) to act on its petition filed over a ...
Woodcliff Lake, NJ, and New York, July 23, 2010 - Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Postradiotherapy Neck Dissection for Lymph Node–Positive Head and Neck Cancer: The Use of Computed Tomography to Manage the Neck Thirty-four patients received donepezil 5 mg/d for 6 weeks, then 10 ...
The observations that the cannabinoid 1 (CB 1) receptor antagonist/inverse agonist, rimonabant, and the selective noncompetitive inhibitor of acetylcholinesterase (AChE), donepezil, improve ...
WOODCLIFF LAKE, N.J. & NEW YORK--(BUSINESS WIRE)-- Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results